When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 14 Mar 2025
Last updated: 28 Jan 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • heartburn
  • acid regurgitation

Other diagnostic factors

  • dysphagia
  • bloating/early satiety
  • laryngitis
  • globus
  • enamel erosion
  • halitosis
  • dyspepsia

Risk factors

  • family history of heartburn or GORD
  • older age
  • hiatus hernia
  • obesity
  • use of lower oesophageal sphincter (LOS) tone-reducing drugs
  • psychological stress
  • asthma
  • use of non-steroidal anti-inflammatory drugs (NSAIDs)
  • smoking
  • alcohol consumption
  • per-oral endoscopic myotomy (POEM)
  • dietary factors
  • pregnancy

Diagnostic investigations

1st investigations to order

  • proton-pump inhibitor (PPI) trial

Investigations to consider

  • oesophagogastroduodenoscopy (OGD)
  • ambulatory pH monitoring
  • oesophageal manometry
  • combined impedance-pH testing
  • barium swallow
  • oesophageal capsule endoscopy

Emerging tests

  • endoluminal functional lumen imaging probe

Treatment algorithm

Contributors

Authors

Marc J. Zuckerman, MD

Professor of Medicine

Chief of Division of Gastroenterology

Texas Tech University Health Sciences Center

El Paso

TX

Disclosures

MJZ is on the speakers bureau for Phathom Pharmaceuticals.

Andres F. Carrion, MD

Associate Professor of Clinical Medicine

Division of Gastroenterology and Hepatology

University of Miami

Miami

FL

Disclosures

AFC declares that he has no competing interests.

Acknowledgements

Dr Marc J. Zuckerman and Dr Andres F. Carrion would like to gratefully acknowledge Dr Sheila Feit and Dr Mohamed Othman, previous contributors to this topic.

Disclosures

SF declares that she has no competing interests. MO has acted as a consultant for Olympus.

Peer reviewers

Lars Aabakken, MD

Professor of Medicine

Chief of GI Endoscopy

Rikshospitalet University Hospital

Oslo

Norway

Disclosures

LA declares that he has no competing interests.

Lise Lotte Gluud, MD, DMSc

Consultant

Department of Internal Medicine

Copenhagen University Hospital

Hellerup

Denmark

Disclosures

LLG declares that she has no competing interests.

Gary W. Falk, MD, MS

Professor of Medicine

Department of Gastroenterology & Hepatology

Center for Swallowing & Esophageal Disorders

Cleveland Clinic

Cleveland

OH

Disclosures

GWF has received fees from: AstraZeneca (consultant, speakers bureau, grant support); Takeda (grant support); Pentax (speaker, travel); Wyeth (consultant); and C2 Therapeutics (consultant).

Use of this content is subject to our disclaimer